These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34465639)

  • 1. Determining the Factors Affecting Long-Term and Short-Term Survival of Breast Cancer Patients in Rafsanjan Using a Mixture Cure Model.
    Jahani S; Hoseini M; Pourhamid R; Askari M; Moslemi A
    J Res Health Sci; 2021 May; 21(2):e00516. PubMed ID: 34465639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Weibull and Lognormal Cure Models with Cox in the Survival Analysis Of Breast Cancer Patients in Rafsanjan.
    Hoseini M; Bahrampour A; Mirzaee M
    J Res Health Sci; 2017 Feb; 17(1):e00369. PubMed ID: 28413171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach.
    Rafati S; Baneshi MR; Bahrampour A
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):485-490. PubMed ID: 32102528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.
    Baghestani AR; Zayeri F; Akbari ME; Shojaee L; Khadembashi N; Shahmirzalou P
    Asian Pac J Cancer Prev; 2015; 16(17):7923-7. PubMed ID: 26625822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the cure rate in Iranian breast cancer patients.
    Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
    Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.
    Azizmohammad Looha M; Pourhoseingholi MA; Nasserinejad M; Najafimehr H; Zali MR
    Epidemiol Health; 2018; 40():e2018045. PubMed ID: 30220192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder.
    Arano I; Sugimoto T; Hamasaki T; Ohno Y
    BMC Med Res Methodol; 2010 Apr; 10():33. PubMed ID: 20412598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Short-Term and Long-Term Survival in Patients Undergoing Hemodialysis Using Semi- Parametric Mixture Cure Models.
    Shayan Z; Ebrahimi V; Ezzatzadegan Jahromi S
    Iran J Kidney Dis; 2020 Jan; 14(1):44-51. PubMed ID: 32156841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes.
    Fendereski A; Hajizadeh E; Haghighat S; Rasekhi A
    BMC Womens Health; 2022 Jul; 22(1):268. PubMed ID: 35787692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors of survival time of breast cancer in kurdistan province of Iran between 2006-2014: a cox regression approach.
    Karimi A; Delpisheh A; Sayehmiri K; Saboori H; Rahimi E
    Asian Pac J Cancer Prev; 2014; 15(19):8483-8. PubMed ID: 25339051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Prognostic Factors of Male Breast Cancer in Southern Iran: a LASSO-Cox Regression Approach.
    Shahraki HR; Salehi A; Zare N
    Asian Pac J Cancer Prev; 2015; 16(15):6773-7. PubMed ID: 26434910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of prognostic factors in long-term survival of male and female patients with colorectal cancer using non-mixture cure model based on the Weibull distribution.
    Azizmohammad Looha M; Zarean E; Masaebi F; Pourhoseingholi MA; Zali MR
    Surg Oncol; 2021 Sep; 38():101562. PubMed ID: 33862578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival in patients with breast cancer referred to Cancer Research Center in Iran.
    Baghestani AR; Shahmirzalou P; Zayeri F; Akbari ME; Hadizadeh M
    Asian Pac J Cancer Prev; 2015; 16(12):5081-4. PubMed ID: 26163645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.
    Nematolahi S; Ayatollahi SMT
    Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data.
    Asano J; Hirakawa A
    J Biopharm Stat; 2017; 27(6):918-932. PubMed ID: 28324665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.
    Meshkat M; Baghestani AR; Zayeri F; Khayamzadeh M; Akbari ME
    Breast J; 2018 Nov; 24(6):1015-1018. PubMed ID: 30270522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data.
    Asano J; Hirakawa A; Hamada C
    Pharm Stat; 2014; 13(6):357-63. PubMed ID: 25044997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixture cure model for estimating short-term and long-term colorectal cancer survival.
    Amanpour F; Akbari S; Azizmohammad Looha M; Abdehagh M; Pourhoseingholi MA
    Gastroenterol Hepatol Bed Bench; 2019; 12(Suppl1):S37-S43. PubMed ID: 32099600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The estimation of long and short term survival time and associated factors of HIV patients using mixture cure rate models.
    Ghobadi KN; Roshanaei G; Poorolajal J; Shakiba E; KHassi K; Mahjub H
    BMC Med Res Methodol; 2023 May; 23(1):123. PubMed ID: 37217850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Survival and Prognostic Factors of Breast Cancer.
    Olfatbakhsh A; Heidari L; Omidi Z; Hashemi EO; Ansari M; Mozaffarian S; Haghighat S
    Arch Iran Med; 2022 Sep; 25(9):609-616. PubMed ID: 37543886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.